Christina D. Williams, Ajeet Gajra, Apar K. Ganti and Michael J. Kelley Use and impact of adjuvant chemotherapy in patients with resected non-small cell lung cancer Cancer 120
Despite clinical trials demonstrating improved survival with adjuvant chemotherapy for patients with American Joint Committee on Cancer stages I to III non–small cell lung cancer, it is unclear whether this survival benefit extends to broader populations. In the current study, a majority of patients did not receive adjuvant chemotherapy. Adjuvant chemotherapy was found to be associated with improvement in overall survival.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf